Status:
UNKNOWN
Comparison of Quality of Life in Moderate Acne Vulgaris Patients Based on Acne-QoL-INA Using Standard Therapy With and Without Acne Lesions Extraction
Lead Sponsor:
Indonesia University
Conditions:
Acne Vulgaris
Quality of Life
Eligibility:
All Genders
18-59 years
Phase:
NA
Brief Summary
This study will compare the quality of life between 2 groups, which are group that receive standard moderate acne therapy in addition of lesion extractions, and the second group which only receive sta...
Detailed Description
The group allocation will be randomized. Outcome of the study is the quality of life score based on Acne-QoL-INA questionnaire. The study duration is 8 weeks, consists of baseline visit and 2 follow u...
Eligibility Criteria
Inclusion
- Clinically diagnosed as moderate acne vulgaris
- Able to read and speak in Indonesia
- Indonesian Citizen
- Sign the consent form
Exclusion
- Pregnant of breastfeeding women
- Acne vulgaris lesion located only outside of face
- Experiencing COVID-19 symptoms
- Using retinoid acid containing cream or benzoil peroxide in the last 2 weeks
- Consume any oral antibiotics in the last 1 month
- Injected with intralesional steroid or having acne lesions extracted in the last 2 weeks
- Having laser or chemical peeling in the last 1 month
Key Trial Info
Start Date :
August 28 2023
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
January 3 2024
Estimated Enrollment :
40 Patients enrolled
Trial Details
Trial ID
NCT06181838
Start Date
August 28 2023
End Date
January 3 2024
Last Update
December 29 2023
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Rumah Sakit Umum Pusat Nasional Dr. Cipto Mangunkusumo
Jakarta Pusat, DKI Jakarta, Indonesia, 10430